在患有严重CRSwNP的患者中,杜皮卢马布的反应开始,维持和持续时间
Claus Bachert1, Asif H Khan2, Wytske J Fokkens3
1University Hospital of Münster, Münster, Germany; First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
The Journal of allergy and clinical immunology
|August 16, 2024
概括
杜皮卢马布治疗具有鼻息肉的慢性鼻炎 (CRSwNP) 显示出快速和持续的症状改善. 大多数患者在第16周经历了显著的缓解,超过52周的持续效益.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 具有鼻息肉的慢性鼻炎 (CRSwNP) 显著影响患者的生活质量.
- 在之前的研究中,dupilumab已经在治疗CRSwNP方面表现出有效性.
- 了解dupilumab反应的时间动态对于临床管理至关重要.
研究的目的:
- 在52周内分析严重CRSwNP患者对dupilumab反应的迅速性,维持性和持续性.
- 根据关键的临床结果指标来评估治疗反应.
主要方法:
- 对来自SINUS-52研究 (NCT02898454) 的数据进行了后期分析.
- 有严重CRSwNP的治疗意向人口接受dupilumab (300 mg每2周一次) 或安慰剂.
- 响应的定义是指鼻息肉评分 (NPS),鼻塞 (NC) 评分,嗅觉丧失 (LoS) 评分和中鼻结局测试 (SNOT-22) 评分的改善.
主要成果:
- 与安慰剂相比,dupilumab在第16周显著改善了NPS,NC,LoS和SNOT-22分数.
- 超过80%的初始响应者在第52周保持了响应.
- 在52周的时间里,Dupilumab响应者在所有结局措施中表现出显著更高的响应持续时间.
结论:
- 在大多数CRSwNP.患者中,在16周内,对杜皮卢马布的临床上有意义的反应很快就会得到.
- 持续使用dupilumab治疗导致52周的治疗反应的维持和持续.
- 杜皮卢马布为治疗严重的CRSwNP提供了一个持续的治疗选择.
相关概念视频
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
103
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
103
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
120
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
120
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
01:17Drugs for Treatment of Diarrhea-Predominant IBS
153
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
153
01:29Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K